About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

High Altitude Medicine & Biology

Editor-in-Chief: John B. West, MD, PhD

ISSN: 1527-0297 • Published Quarterly • Online ISSN: 1557-8682

Current Volume: 15

Latest Impact Factor* is 1.818

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    HIGH ALTITUDE MEDICINE & BIOLOGY is a quarterly peer-reviewed journal that publishes original research papers, review papers, and short communications. Contributions are welcome in the fields of high altitude diseases and other high altitude life sciences, including physiology, pathology, comparative biology, anthropology, evolutionary biology, and human and animal ecology. The journal has a strong interdisciplinary coverage.


    All new manuscripts must be submitted online at
    http://mc.manuscriptcentral.com/highaltitudemedicine


    Research Paper

     Prepare the entire manuscript including references, tables, and figure legends double-spaced with one-inch margins on all sides.
     

    On the first page, give the title of the paper, full name(s) of all author(s), institutional affiliation(s), and the name (with complete address, phone and fax numbers, and e-mail address) to whom correspondence should be directed. We require the full mailing address and contact information (telephone, fax, and e-mail address) for EACH author listed on your paper.  Please also indicate the corresponding author. Supply a running title of no more than 40 characters (including spaces). On the second page, supply an abstract of about 200 words, stating the aims, results, and conclusions drawn from the study and 5-6 key words to help with indexing. You will also be asked to enter the abstract and keywords online during the submission process.

    This should be followed by the introduction, materials and methods, results, discussion, conclusion, disclosure statement, acknowledgments, references, tables, figure legends, and figures.

    Results and discussion should be separate sections. Number pages consecutively; the first author's last name should appear on each page. Authors should review the style and clarity of their manuscripts with colleagues before submission. Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage.

    All papers will be sent to two or more expert reviewers for their opinions. The editor welcomes suggestions concerning potential reviewers. You will have the opportunity to suggest reviewers during the online submission process, however, reviewer selection is at the discretion of the Editor.  A valid email address for suggested reviewers is required.

    Studies involving human subjects or experimental animals should explicitly state that the protocols were reviewed by the appropriate institutional review committees and that, in the case of human subjects, informed consent was obtained. Any possible financial conflicts of interest, for example in drug studies, should be disclosed.
     

    Brief Reports and Letters to the Editor

    Submission of Brief Reports is also welcome. A Brief Report should communicate new scientific or methodological information in the field of high altitude medicine and biology. It should be divided as follows: abstract (no more than 200 words), introduction, materials and methods, results and discussion (please note that in Brief Reports, results and discussion can be fused), acknowledgments, references, tables, figure legends, and figures. The whole report should be composed of no more than four journal pages (about 3,000 words), including tables and figures. For general rules please follow the guidelines given for research papers. Letters to the Editor are also welcome but should not exceed 600 words and one illustration.

    Tables and Illustrations
     

    Prepare each table with its title in a separate file. Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.


    Please submit artwork according to the following guidelines:
     

    • Do NOT include any illustrations as part of your text file.
    • Do NOT prepare any figures in Word as they are not workable.
    • Line illustrations must be submitted at 1200 DPI.
    • Halftones and color photos should be submitted at 300 DPI.
    • Please submit only TIFF or EPS files.
    • Color art must be saved as CYMK not RGB or INDEX. If RGB files are submitted, the files will be converted
       to CYMK, and some slight color variation may occur.
    • Do NOT submit PowerPoint or Excel files. Adobe is the software of choice.
     

    Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc.  Authors who do not follow these guidelines may have their submission returned to them without being reviewed.

    You will be given directions on how to correct any files which do not pass.

    ADDITIONAL INFORMATION ABOUT ART FILES

    Converting Word or Excel files:  Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines: 

    • All files should be scanned at 100% size.
    • 300 dpi
    • Final color mode: cmyk
    • save file as: .tif or .eps

    If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf

    AUTHOR DISCLOSURE

    All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section. 

    References 

    All references should be cited by author(s) and dates within the text [i.e., In some studies, REM sleep is virtually abolished at high altitude (Pappenheimer, 1977)]. If more than two authors are involved, use et al. after the first author's name [i.e., (Lahiri et al., 1999)]. If more than one paper by the same author(s) and year is cited in the text, use a lower case letter designation to indicate the individual paper [i.e., (Smith, 1984a)]. Use the same designation in the reference list. 

    The reference list should be double-spaced and listed in alphabetical order at the end of the paper. Each reference should include a complete list of authors and the complete title of the cited paper, as follows: 

    Journal citation:  Lahiri S., Smatresk N., Pokorski M., Barnard P., Mokashi A., and McGregor K.H. (1984). Dopaminergic efferent inhibition of carotid body chemoreceptors in chronically hypoxic cats. Am. J. Physiol. 247:R24-R28. 

    Chapter in an edited book:  Weil J.V., Kryger M.H., and Scoggin C.H. (1978). Sleep and breathing at high altitude. In: Sleep Apnea Syndromes. C. Guilleminault and W. Dement, eds. Liss, New York; pp. 119-136. 

    Entire book:  Barcroft J. (1925). The Respiratory Function of the Blood. Part I: Lessons from High Altitude. Cambridge University Press, Cambridge, UK. 

    If work is in press, give the journal in which it is to be published. Abbreviations of journal names should follow the style of Medline. 

    Permissions 

    The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained (by the author) from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure should read "reprinted by permission from Jones et al. (1991)" and the appropriate reference should be cited in the reference list. All permission listings must be shown in the manuscript; they cannot be entered on proofs. 

    Manuscripts submitted to this journal must not be under consideration elsewhere. 

    REPRINTS

    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

    PUBLISHER 

    The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; fax: (914) 740–2101.   info@liebertpub.com on-line: www.liebertpub.com 

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy


    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

     

    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 

     

     

     

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Journal of Aerosol Medicine
    and Pulmonary Drug Delivery

    Journal of Aerosol Medicine
    and Pulmonary Drug Delivery

    Coverage includes particle and gas inhalation in the respiratory tract, aerosol use as tools to study basic physiologic phenomena, aerosol drug delivery of medication, measurement of respiratory secretions, and more.

    Pediatric Allergy, Immunology, and Pulmonology

    Pediatric Allergy, Immunology, and Pulmonology

    Original, clinical epidemiologic research on the most common chronic illnesses of children—asthma and allergies—as well as many less common and rare diseases.

    Telemedicine and e-Health

    Telemedicine and e-Health

    The leading international peer-reviewed journal covering the advances and clinical applications of telemedicine and management of electronic health records.

    Astrobiology

    Astrobiology

    The leading peer-reviewed journal dedicated to advancing our understanding of life’s origin, evolution, and distribution in the universe.

Browse All Publications »